
100, 100: Breakthrough T1D Research Leads to a New Class of Glucose-Lowering Agents
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQV2xmVGI4cTBQZ2xURnJwSHdUS3N3TmxKWHBnd3hkUXphWE5CU3Z4c0JwdWtKM1B1ZVJvMUtCOWNrZm5jRGtDTDNUbkY5V1k5bUtuY3BuS1FVN18xTkttcVZVYTk2bnhGUXplcXlNeVV4YVpPODA5MlE5SEw2TkJtYldwaW4xb0NNRlk4UTFTamxqdXdMSkhCbzh5Nk5qNzB3QVhlQms2MUYzSUE2c2pUNw?oc=5" target="_blank">100, 100: Breakthrough T1D Research Leads to a New Class of Glucose-Lowering Agents</a>&nbsp;&nbsp;<font color="#6f6f6f">Breakthrough T1D</font>